Clinical Trials Browser

Phase 2 × Re-Irradiation × 90 days × Clear all

NCT03743662 2026-01-07

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Phase 2 Active not recruiting

Glioblastoma